Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Chondrosarcoma × Loperamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Sarcoma, Alveolar Soft Part 1 Chondrosarcoma 1

Interventions

belinostat 2 Gemcitabine 2 Fluorouracil 2 venetoclax 1 toripalimab 1 tazemetostat 1 resiquimod 1 poly ICLC 1 perifosine 1 pazopanib 1 envafolimab 1 enasidenib 1 durvalumab 1 drozitumab 1 birinapant 1 Medicare Part B 1 Loperamide 1 Leucovorin 1 Irinotecan 1 Imatinib Mesylate 1 IPI-926 1 IFL protocol 1 Fentanyl 1 Doxorubicin 1 Docetaxel 1 Cisplatin 1 Bevacizumab 1 Azacitidine 1 Antiemetics 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

AEterna Zentaris

Phase 2 Completed

Chondrosarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡